Tongjitang Chinese Medicines Co. (ADR) (NYSE:TCM)

CAPS Rating: 3 out of 5

A vertically integrated and profitable specialty pharmaceutical company focusing on the development, manufacturing and marketing of modernized traditional Chinese medicine.

Recs

0
Player Avatar JestYourFool (< 20) Submitted: 4/2/2010 7:18:55 AM : Outperform Start Price: $3.70 TCM Score: +8.29

Near 52-week low - healthcare for the Chinese population? If China allows capitalistic companies, great opportunities.

Featured Broker Partners


Advertisement